"head and neck cancer" trang 9 - tải miễn phí từ tailieunhanh
Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models

Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models
9    41    1
Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas

Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas
11    58    1
Perioperative mortality of head and neck cancers

Perioperative mortality of head and neck cancers
9    48    1
Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: A population-based study

Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: A population-based study
16    19    1
Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma

Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
9    45    1
A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma

A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma
13    58    1
Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma

Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma
11    34    1
Circ_0000045 promotes proliferation, migration, and invasion of head and neck squamous cell carcinomas via regulating HSP70 and MAPK pathway

Circ_0000045 promotes proliferation, migration, and invasion of head and neck squamous cell carcinomas via regulating HSP70 and MAPK pathway
16    20    1
Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: A phase I trial

Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: A phase I trial
10    21    2
Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (≥6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: A retrospective study

Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (≥6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: A retrospective study
6    1    1
Hypofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: Study protocol of the phase I HYDRA trial

Hypofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: Study protocol of the phase I HYDRA trial
8    7    1
MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma

MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma
14    1    1
Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas

Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas
12    1    1
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: A multicenter retrospective study from Japan

Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: A multicenter retrospective study from Japan
9    6    1
Anti-cancer effect of 131I-nimotuzumab on immune deficiency mouse bearing human larynx cancer

Anti-cancer effect of 131I-nimotuzumab on immune deficiency mouse bearing human larynx cancer
8    115    0
Head and Neck Cancer Edited by Mark Agulnik

Head and Neck Cancer Edited by Mark Agulnik
440    68    0
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer

A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer
15    8    1
αB-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinoma

αB-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinoma
8    73    1
Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe

Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe
12    26    1
Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma

Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma
10    1    1